Exclusive offer for Mark Roberge CRO event attendees: Scaling Effectiveness Diagnostic. Live in 14 Days. Learn more
Learn more
According to Gartner, only 7% of sales organizations achieve forecast accuracy of 90% or higher. Read that again. It means that 93% of Chief Revenue Officers walking into next quarter's board meeting will deliver a number that is off by more than ten points.
.png)
This is not a problem of a few struggling outliers. It is the median experience of revenue leadership today. Sales forecasting, for all the investment poured into it, fails most of the people who depend on it. And it is failing despite the largest investment in revenue technology in history.
Bain & Company recently found that while 91% of sales leaders are confident they will hit their targets, nearly half failed to do so last year. The average tenure of a CRO, according to Harvard Business Review, is now just 25 months, among the shortest of any role in the C-suite. The connection between these numbers is not a coincidence. CROs are losing their seats because their sales forecasting cannot reliably tell them what is coming.
Here is what makes the sales forecasting crisis so strange: the gap is not closing despite enormous investment. It may be widening because of where that investment has gone.
The modern revenue stack is the most sophisticated it has ever been. Conversation intelligence platforms transcribe and analyze every customer call. Revenue intelligence tools track which slides a buyer viewed and for how long. Sales engagement platforms recommend the next best action on every open opportunity. Attribution software maps every touch in the buyer journey.
Every CRO today has more tooling than any revenue leader did five years ago. And yet quota attainment has fallen. A decade ago, roughly 53% of B2B sales reps hit quota. Today, by some measures, that number is closer to 25%.
So why isn't the performance gap closing? Why does sales forecasting keep missing even as the instruments multiply?
After hundreds of conversations with CROs, CFOs, and board members, a clear pattern emerges. The industry has spent the last decade obsessing over deal-level visibility.
This is the surface of the water, and it is beautifully instrumented. We can tell you the sentiment on every call, the engagement on every email, the next best action on every deal. But a microscope, however powerful, is the wrong instrument for navigating a ship. You cannot steer around what you cannot see, and the deal-level view shows you only what is directly in front of you, right now.
The risks that actually break sales forecasting are not deal-level events. They are systemic. They form slowly, beneath the surface, across segments and quarters, and they do not show up in any individual deal until it is too late to act.
There are three recurring systemic risks that surface three to six months ahead of any deal-level dashboard. We call them the icebergs.
Next quarter, a segment of your pipeline, often the enterprise segment, is going to deliver less than your model assumed. The leading indicators of this shortfall, the conversion trends, the capacity gaps, the lead velocity decay, are visible now. But your deal-level data will not ring the alarm, because by the time individual deals start slipping, the macro shortfall is already locked in. Your sales forecasting discovers it in the quarter it happens, not the quarter you could have prevented it.
Your existing customers are buying less than their potential, and the white-space gap is widening silently. Net revenue retention is a lagging indicator: by the time it shows up in your renewal numbers, the expansion revenue is already lost. The signal that an account is under-expanding appears months before the renewal, but only if you are measuring expansion potential rather than expansion bookings.
This is the most dangerous iceberg because it is the slowest. Over time, the customers your reps are actually closing drift away from your stated ideal customer profile. Your ICP, the one in your board deck, describes who you intended to sell to. Your actual customer profile describes who your reps actually sell to under quota pressure, which is usually whoever is easiest to close this quarter. The two diverge gradually, and you discover the gap a year later, when win rates in your core segment collapse because you stopped selling to it.
Underlying all three icebergs is a deeper truth that Mark Roberge articulates in The Science of Scaling: product-market fit is retention, not revenue or logo count.
You can sell a million dollars of software to a hundred customers and watch all of them churn. Revenue and logos are lagging indicators of fit. Retention is the real signal, and because retention itself is lagging, the discipline is to instrument a Leading Indicator of Retention, or LIR: the measurable behavior that predicts whether a customer will stay.
A LIR takes the form of P percent of customers perform event E every period T. Slack measured the percentage of customers sending 2,000 team messages a month. HubSpot measured customers using five or more features a month. The specific metric varies by business, but the principle is universal: find the early behavioral signal that predicts retention, and track it before revenue confirms or denies it.
The implication for board reporting is significant. The LIR chart, not the income statement, should arguably be the first slide in an early-stage board deck. Most companies discover they have lost product-market fit roughly nine months after the pipeline actually broke, because they were watching the lagging financial indicators instead of the leading behavioral ones.
Improving sales forecast accuracy requires a different layer of measurement than deal inspection provides. Three practices help:
Measure leading indicators, not lagging ones. For every lagging metric you report (revenue, retention, win rate), identify the leading indicator that predicts it three to six months earlier, and report that instead. This single shift does more for sales forecast accuracy than any new deal-inspection tool.
Segment everything. Systemic risks hide in blended averages. A healthy company-wide win rate can conceal an enterprise segment that is collapsing while mid-market masks the decline. Always view conversion, retention, and expansion by segment.
Compare your actual customer profile to your stated ICP continuously. Modern revenue analytics can run an LTV-to-CAC calculation dynamically across dozens of weighted account attributes, rather than the static five-field ICP definition most teams still use. This surfaces ICP drift while you can still correct it.
The final discipline is to treat scale as a pace rather than a lump-sum hiring event after a fundraise. You establish a quarterly hiring cadence that only throttles up or down based on the signals of the business: rep productivity, quota attainment, and the percentage of new customers hitting your LIR.
Crucially, you negotiate the accelerate-decelerate-hold criteria with your board in advance, so the difficult Q3 conversation runs on data rather than emotion. This is only possible if you are measuring the leading indicators that justify each decision, which brings the entire framework back to its foundation: you cannot scale with evidence, and you cannot forecast with accuracy, if you can only see the surface of the water.
The next decade of revenue performance will not be won at the deal level. Deal-level visibility is now a commodity; every competitor has the same microscopes. Sales forecasting will be won at the systemic level, by the revenue leaders who can see their pipeline shape, segment health, and ICP fit months before any of those things become deal-level events.
The question for any CRO heading into board season is not whether they have enough deal-level visibility. It is this: what is gathering beneath the surface that the dashboards cannot yet see?
Join revenue leaders across high-growth B2B companies who are using SkyGeni to spot risk earlier, build better pipeline, and grow predictably.
Empowering revenue teams to plan with precision, execute with confidence, outmaneuver competitors, and expand Lifetime Value. Let’s accelerate predictable revenue growth, together.
